Former Johnson & Johnson, Bristol Myers Squibb executive to lead COTA April 12, 2022 Auto Bot Clinical Development 0 Miruna Sasu has been named president and CEO of the company, which uses RWD and analytics in advancing oncology drug development and clinical trial diversity.